327 related articles for article (PubMed ID: 9342133)
21. Combined alfentanil-methohexital anesthesia in electroconvulsive therapy.
Dinwiddie SH; Isenberg KE
Convuls Ther; 1995 Sep; 11(3):170-6. PubMed ID: 8528658
[TBL] [Abstract][Full Text] [Related]
22. Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time.
Papakostas Y; Markianos M; Pehlivanidis A; Papadimitriou GN; Zervas IM; Daras M; Stefanis C
Biol Psychiatry; 1996 Mar; 39(6):444-7. PubMed ID: 8679790
[TBL] [Abstract][Full Text] [Related]
23. ECT in the presence of intracranial aneurysm.
Najjar F; Guttmacher LB
J ECT; 1998 Dec; 14(4):266-71. PubMed ID: 9871849
[TBL] [Abstract][Full Text] [Related]
24. Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy.
Sakamoto A; Ogawa R; Suzuki H; Kimura M; Okubo Y; Fujiya T
Psychiatry Clin Neurosci; 2004 Dec; 58(6):630-5. PubMed ID: 15601388
[TBL] [Abstract][Full Text] [Related]
25. Effects of remifentanil on convulsion duration and hemodynamic responses during electroconvulsive therapy: a double-blind, randomized clinical trial.
Nasseri K; Arasteh MT; Maroufi A; Shami S
J ECT; 2009 Sep; 25(3):170-3. PubMed ID: 19755938
[TBL] [Abstract][Full Text] [Related]
26. Ictal electroencephalographic characteristics during electroconvulsive therapy: a review of determination and clinical relevance.
Mayur P
J ECT; 2006 Sep; 22(3):213-7. PubMed ID: 16957539
[TBL] [Abstract][Full Text] [Related]
27. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
Gupta A; Naik A; Vora A; Lokhandwala Y
J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689
[TBL] [Abstract][Full Text] [Related]
28. Anaesthesia for electroconvulsive therapy: use of propofol revisited.
Fredman B; Husain MM; White PF
Eur J Anaesthesiol; 1994 Sep; 11(5):423-5. PubMed ID: 7988589
[TBL] [Abstract][Full Text] [Related]
29. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
Howie MB; Hiestand DC; Zvara DA; Kim PY; McSweeney TD; Coffman JA
Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy.
Kovac AL; Goto H; Pardo MP; Arakawa K
Can J Anaesth; 1991 Mar; 38(2):204-9. PubMed ID: 1673645
[TBL] [Abstract][Full Text] [Related]
31. Prediction of antidepressant response in both 2.25xthreshold RUL and fixed high dose RUL ECT.
Kimball JN; Rosenquist PB; Dunn A; McCall WV
J Affect Disord; 2009 Jan; 112(1-3):85-91. PubMed ID: 18539340
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine blunts acute hyperdynamic responses to electroconvulsive therapy without altering seizure duration.
Begec Z; Toprak HI; Demirbilek S; Erdil F; Onal D; Ersoy MO
Acta Anaesthesiol Scand; 2008 Feb; 52(2):302-6. PubMed ID: 17976228
[TBL] [Abstract][Full Text] [Related]
33. Effects of caffeine pretreatment on measures of seizure impact.
Rosenquist PB; McCall WV; Farah A; Reboussin DM
Convuls Ther; 1994 Jun; 10(2):181-5. PubMed ID: 8069645
[TBL] [Abstract][Full Text] [Related]
34. Outcome of four pretreatment regimes on hemodynamics during electroconvulsive therapy: A double-blind randomized controlled crossover trial.
Parikh DA; Garg SN; Dalvi NP; Surana PP; Sannakki D; Tendolkar BA
Ann Card Anaesth; 2017; 20(1):93-99. PubMed ID: 28074804
[TBL] [Abstract][Full Text] [Related]
35. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
Baghai TC; Marcuse A; Brosch M; Schüle C; Eser D; Nothdurfter C; Steng Y; Noack I; Pietschmann K; Möller HJ; Rupprecht R
World J Biol Psychiatry; 2006; 7(2):82-90. PubMed ID: 16684680
[TBL] [Abstract][Full Text] [Related]
36. The significance of clinical EEG abnormalities in depressed patients treated with ECT.
Malaspina D; Devanand DP; Krueger RB; Prudic J; Sackeim HA
Convuls Ther; 1994 Dec; 10(4):259-66. PubMed ID: 7850395
[TBL] [Abstract][Full Text] [Related]
37. Triazolam and diphenhydramine effects on seizure duration in depressed patients receiving ECT.
Guthrie SK; Sung JC; Goodson J; Grunhaus L; Tandon R
Convuls Ther; 1996 Dec; 12(4):261-5. PubMed ID: 9034702
[No Abstract] [Full Text] [Related]
38. Aminophylline increases seizure length during electroconvulsive therapy.
Stern L; Dannon PN; Hirschmann S; Schriber S; Amytal D; Dolberg OT; Grunhaus L
J ECT; 1999 Dec; 15(4):252-7. PubMed ID: 10614031
[TBL] [Abstract][Full Text] [Related]
39. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy.
Howie MB; Black HA; Zvara D; McSweeney TD; Martin DJ; Coffman JA
Anesth Analg; 1990 Oct; 71(4):384-8. PubMed ID: 1975995
[TBL] [Abstract][Full Text] [Related]
40. Exceptionally high seizure threshold: ECT device limitations.
Lisanby SH; Devanand DP; Nobler MS; Prudic J; Mullen L; Sackeim HA
Convuls Ther; 1996 Sep; 12(3):156-64. PubMed ID: 8872404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
